Trademark: 97407218
Word
SHORLA ONCOLOGY
Status
Registered
Status Code
700
Status Date
Tuesday, August 8, 2023
Serial Number
97407218
Registration Number
7130540
Registration Date
Tuesday, August 8, 2023
Mark Type
4000
Filing Date
Thursday, May 12, 2022
Published for Opposition
Tuesday, May 23, 2023

Trademark Owner History
Shorla Pharma Limited - Original Registrant

Classifications
5 pharmaceutical and medicinal preparations and substances for the treatment of metabolic diseases and disorders, oncological diseases and disorders, dermatological diseases and disorders, hormonal diseases and disorders, viral diseases and disorders, bacterial diseases and disorders, infectious diseases and disorders, viral diseases and disorder, as well as diseases and disorders of the alimentary tract, cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system, and respiratory system; pharmaceutical and medicinal preparations and substances for use in oncology; pharmaceutical preparations, products and substances for human use for the treatment of metabolic diseases and disorders, oncological diseases and disorders, dermatological diseases and disorders, hormonal diseases and disorders, viral diseases and disorders, bacterial diseases and disorders, infectious diseases and disorders, viral diseases and disorder, as well as diseases and disorders of the alimentary tract, cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system, and respiratory system; pharmaceutical preparations and substances for the prevention and treatment of cancer; pharmaceutical compounds for treating cancer; biological preparations for the treatment of cancer; pharmaceutical preparations and substances for the prevention of tumours; anti-cancer drugs and pharmaceutical preparations
42 research and development services in the field of metabolic diseases and disorders, oncological diseases and disorders, dermatological diseases and disorders, hormonal diseases and disorders, viral diseases and disorders, bacterial diseases and disorders, infectious diseases and disorders, viral diseases and disorder, as well as diseases and disorders of the alimentary tract, cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system, and respiratory system; biological research; scientific research services; research and development services in the pharmaceutical and biotechnology fields; research services relating to the development and testing of pharmaceutical preparations and medicines; pharmaceutical drug development services; pharmaceutical product evaluation; testing and inspection of pharmaceutical preparations and medicines; product safety and quality testing in the pharmaceutical and biotechnology fields; provision of information and data relating to research and development in the pharmaceutical and biotechnology fields
"ONCOLOGY"

Trademark Events
Aug 8, 2023
Notice Of Registration Confirmation Emailed
Aug 8, 2023
Registered-Principal Register
May 23, 2023
Official Gazette Publication Confirmation E-Mailed
May 23, 2023
Published For Opposition
May 3, 2023
Notification Of Notice Of Publication E-Mailed
Apr 19, 2023
Approved For Pub - Principal Register
Apr 19, 2023
Examiner's Amendment Entered
Apr 19, 2023
Notification Of Examiners Amendment E-Mailed
Apr 19, 2023
Examiners Amendment E-Mailed
Apr 19, 2023
Examiners Amendment -Written
Apr 6, 2023
Teas/Email Correspondence Entered
Apr 6, 2023
Correspondence Received In Law Office
Apr 6, 2023
Teas Response To Office Action Received
Mar 8, 2023
Notification Of Non-Final Action E-Mailed
Mar 8, 2023
Non-Final Action E-Mailed
Mar 8, 2023
Non-Final Action Written
Mar 1, 2023
Assigned To Examiner
Sep 3, 2022
Preliminary/Voluntary Amendment - Entered
Sep 2, 2022
Assigned To Lie
Aug 3, 2022
Teas Voluntary Amendment Received
May 17, 2022
New Application Office Supplied Data Entered
May 16, 2022
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24